AI-driven RNA drug discovery

Atomic AI’s proprietary research and development platform seamlessly integrates cutting-edge deep learning foundation models with specially designed in-house wet-lab assays, thereby establishing a powerful and synergistic cycle for discovering and developing highly potent as well as selectively targeted RNA-targeted and RNA-based small molecules. A fundamental cornerstone of this advanced platform is ATOM-1™, an innovative and first-of-its-kind large language model that skillfully leverages chemical mapping data to significantly streamline the optimization process. ATOM-1 enables exceptionally precise predictions of both RNA structural and functional properties, alongside critical characteristics of various RNA-based modalities – which include small molecules, mRNA vaccines, siRNAs, and circular RNA – ultimately enhancing the overall design and development of groundbreaking therapeutics.